Literature DB >> 16196497

Extracellular protease activation of chemotherapeutics from hydrogel matrices: a new paradigm for local chemotherapy.

Jovita R Tauro1, Richard A Gemeinhart.   

Abstract

A novel paradigm for local cancer chemotherapy, based upon local activation of chemotherapeutic molecules by soluble proteases, is presented. In the presence of matrix metalloproteases, a family of cancer-associated proteases, cisplatin is released from a hydrogel matrix in an active form. In the absence of matrix metalloproteases, cisplatin is released at a much lower rate. The mesh size of the polymer controls metalloprotease-based cisplatin release from the hydrogel matrix with approximate doubling of cisplatin release in the presence of matrix metalloprotease. Overall, this novel paradigm shows much potential for local chemotherapy where local chemotherapeutic release is in response to the invasive properties of the tumor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16196497     DOI: 10.1021/mp050028n

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  7 in total

1.  Novel cyclopeptides for the design of MMP directed delivery devices: a novel smart delivery paradigm.

Authors:  El-Farouck Moustoifa; Mohamed-Anis Alouini; Arnaud Salaün; Thomas Berthelot; Aghleb Bartegi; Sandra Albenque-Rubio; Gérard Déléris
Journal:  Pharm Res       Date:  2010-05-08       Impact factor: 4.200

2.  Effects of molecular weight and loading on matrix metalloproteinase-2 mediated release from poly(ethylene glycol) diacrylate hydrogels.

Authors:  Amy E Ross; Mary Y Tang; Richard A Gemeinhart
Journal:  AAPS J       Date:  2012-04-26       Impact factor: 4.009

3.  Improving matrix metalloproteinase-2 specific response of a hydrogel system using electrophoresis.

Authors:  Yu Zhang; Richard A Gemeinhart
Journal:  Int J Pharm       Date:  2012-03-13       Impact factor: 5.875

4.  Matrix metalloprotease selective peptide substrates cleavage within hydrogel matrices for cancer chemotherapy activation.

Authors:  Jovita R Tauro; Bao-Shiang Lee; Syed S Lateef; Richard A Gemeinhart
Journal:  Peptides       Date:  2008-07-05       Impact factor: 3.750

Review 5.  Nanotechnology-based drug delivery systems for treatment of oral cancer: a review.

Authors:  Giovana Calixto; Jéssica Bernegossi; Bruno Fonseca-Santos; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2014-08-08

6.  In-house preparation of hydrogels for batch affinity purification of glutathione S-transferase tagged recombinant proteins.

Authors:  Jason S Buhrman; Jamie E Rayahin; Melanie Köllmer; Richard A Gemeinhart
Journal:  BMC Biotechnol       Date:  2012-09-18       Impact factor: 2.563

7.  Toroidal-spiral particles for codelivery of anti-VEGFR-2 antibody and irinotecan: a potential implant to hinder recurrence of glioblastoma multiforme.

Authors:  Vishal Sharma; Melanie Köllmer; Magdalena Szymusiak; Ludwig C Nitsche; Richard A Gemeinhart; Ying Liu
Journal:  Biomacromolecules       Date:  2014-02-11       Impact factor: 6.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.